Advertisement

The LEC Rat pp 273-279 | Cite as

Altered Oncogene Expression in Hepatocellular Carcinomas Developing Spontaneously in LEC Rats

  • Minako Nagao
  • Yoshinori Fujimoto
  • Yukihito Ishizaka
  • Katsuhiko Enomoto
  • Hidetoshi Takahashi
  • Michio Mori
  • Takashi Sugimura

Abstract

LEC rats spontaneously suffer hepatitis at around 4 months after birth, enter the chronic phase of hepatitis, and spontaneously develop hepatocellular carcinomas (HCCs) between 1 – 1.5 years after birth [1]. Although dominant oncogene activation in chemically induced HCCs in rats is generally understood to be relatively rare, for the LEC rat, in which an endogenous causative agent appears to be involved, the situation remains unclear. Ha-ras activation has been found with a very high frequency in both chemically induced and spontaneously induced liver carcinomas of B6C3 F1 mice [2–5], but, with the exception of those induced by aflatoxin B1 [6, 7], any type of activated ras was only rarely observed in chemically induced rat liver tumors [4, 8, 9]. We examined HCCs in LEC rats for Ha-, Ki- and N-ras gene mutations. The Polymerase chain reaction (PCR) was adopted for amplifying discrete specific DNA fragments [10, 11], and the sequences were determined directly.

Keywords

Hyperplastic Nodule Single Cell Necrosis National Cancer Center Research Institute B6C3FI Mouse Hereditary Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Masuda R, Yoshida M, Sasaki M, Dempo K, Mori M (1988) High susceptibility to hepatocellular carcinoma development in LEC rats with hereditary hepatitis. Jpn J Cancer Res 79:828–835.PubMedCrossRefGoogle Scholar
  2. 2.
    Beer DG, Pitot HC (1989) Proto-oncogene activation during chemically induced hepatocarcinogenesis in rodents. Mutat Res 220:1–10.PubMedGoogle Scholar
  3. 3.
    Wiseman RW, Stower SJ, Miller EC, Anderson MW, Miller JA (1986) Activating mutations of the c-Ha-ras proto-oncogene in chemically induced hepatomas of the male B6C3 F1 mouse. Proc Natl Acad Sci USA 83:5825–5829.PubMedCrossRefGoogle Scholar
  4. 4.
    Stower SJ, Wiseman RW, Ward JM, Miller EC, Miller JA, Anderson MW, Eva A (1988) Detection of activated proto-oncogene in N-nitrosodiethylamineinduced liver tumors: A comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis 9:271–276.CrossRefGoogle Scholar
  5. 5.
    Reynolds SH, Stower SJ, Maronpot RR, Anderson MW, Aaronson SA (1986) Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci USA 83:33–37.PubMedCrossRefGoogle Scholar
  6. 6.
    Sinha S, Webber C, Marshall CJ, Knowles MA, Proctor A, Barrass NC, Neal GE (1988) Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. Proc Natl Acad Sci USA 85:3673–3677.PubMedCrossRefGoogle Scholar
  7. 7.
    McMahon G, Hanson L, Lee J, Wogan GN (1986) Identification of an activated c-Ki-ras oncogene in rat liver tumors induced by aflatoxin B1. Proc Natl Acad Sci USA 83:9418–9422.PubMedCrossRefGoogle Scholar
  8. 8.
    Watatani M, Perantoni AO, Reed CD, Enomoto T, Wenk ML, Rice JM (1989) Infrequent activation of K-ras, H-ras, and other oncogenes in hepatocellular neoplasms initiated by methyl (acetoxymethyl)-nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats. Cancer Res 49:1103–1109.PubMedGoogle Scholar
  9. 9.
    Li H, Lee G-H, Cui L, Liu J, Nomura K, Ohtaka K, Kitagawa T (1990) Absence of H-ras point mutation at codon 12 in N-methyl-N-nitrosourea-induced hepatocellular neoplasms in the rat. J Cancer Res Clin Oncol 116:331–335.PubMedCrossRefGoogle Scholar
  10. 10.
    Saiki R, Gelfand D, Stoffel S, Sharf S, Higuchi R, Torn G, Mullis K, Erlich H (1988) Primer-directed enzymatic amplification of DNA with a thermostable DNA Polymerase. Science 239:487–491.PubMedCrossRefGoogle Scholar
  11. 11.
    Gyllensten UB, Erlich HA (1988) Generation of single-stranded DNA by the Polymerase chain reaction and application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA 85:7652–7656.PubMedCrossRefGoogle Scholar
  12. 12.
    Makino R, Hayashi K, Sato S, Sugimura T (1984) Expressions of the c-Ha-ras and c-myc genes in rat liver tumors. Biochem Biophys Res Commun 119: 1096–1102.CrossRefGoogle Scholar
  13. 13.
    Tashiro F, Morimura S, Hayashi K, Makino R, Sugimura T, Kawamura H, Horikoshi N, Nemoto K, Ohtsubo K, Sugimura T, Ueno Y (1986) Expression of the c-Ha-ras and c-myc genes in aflatoxin B1-induced hepatocellular carcinomas. Biochem Biophys Res Commun 138:858–864.PubMedCrossRefGoogle Scholar
  14. 14.
    Suchy BK, Sarafoff M, Kerler R, Robes HM (1989) Amplification, rearrangements, and enhanced expression of c-myc in chemically induced rat liver tumors in vivo and in vitro. Cancer Res 49:6781–6787.PubMedGoogle Scholar
  15. 15.
    Chandar N, Lombardi B, Locker J (1989) c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet. Proc Natl Acad Sci USA 86: 2703–2707.PubMedCrossRefGoogle Scholar
  16. 16.
    Beer DC, Neveu MJ, Paul DL, Rapp PU, Pitot HC (1988) Expression of the c-raf proto-oncogene, γ-glutamyltranspeptidase, and gap junction protein in rat liver neoplasms. Cancer Res 48:1610–1617.PubMedGoogle Scholar
  17. 17.
    Sakai R, Ikeda I, Kitani H, Fujiki H, Takaku F, Rapp U, Sugimura T, Nagao M (1989) Flat reversion by okadaic acid of raf and ret-II transformants. Proc Natl Acad Sci USA 86:9946–9950.PubMedCrossRefGoogle Scholar
  18. 18.
    Nagao M, Sakai R, Kitagawa Y, Ikeda I, Sasaki K, Shima H, Sugimura T (1990) Role of protein phosphatases in malignant transformation. In: Knudson AG, Stanbridge EJ, Sugimura T, Terada M, Watanabe S (eds) Genetic basis for carcinogenesis: Tumor suppressor genes and oncogenes. pp. 177-184, Japan Scientific Society Tokyo/Taylor and Fransis, London.Google Scholar
  19. 19.
    Kitagawa Y, Sakai R, Tahira T, Tsuda H, Ito N, Sugimura T, Nagao M (1988) Molecular cloning of phosphoprotein Phosphatase 2Aβ cDNA and increased expression of Phosphatase 2Aa and 2Aβ in rat liver tumors. Biochem Biophys Res Commun 157:821–827.PubMedCrossRefGoogle Scholar
  20. 20.
    Sasaki K, Shima H, Kitagawa Y, Irino S, Sugimura T, Nagao M (1990) Identification of members of the protein Phosphatase l gene family in the rat and enhanced expression of protein Phosphatase la gene in rat hepatocellular carcinomas. Jpn J Cancer Res 81:1272–1280.PubMedCrossRefGoogle Scholar
  21. 21.
    Fujimoto Y, Ishizaka Y, Tahira T, Sone H, Takahashi H, Enomoto K, Mori M, Sugimura T, Nagao M (to be published) Possible involvement of c-myc but not ras genes in hepatocellular carcinomas developing after spontaneous hepatitis in LEC rats. Mol Careinogenesis.Google Scholar
  22. 22.
    Yoshida M, Masuda R, Sasaki M, Takeichi N, Kobayashi H, Dempo K, Mori M (1987) New mutation causing hereditary hepatitis in the laboratory rat. J Hered 78:361–365.PubMedGoogle Scholar
  23. 23.
    Li Y, Togashi Y, Sato S, Emoto T, Kang J, Takeichi N, Kobayashi H, Kojima Y, Une Y, Uchino J (1991) Spontaneous hepatic copper accumulation in LEC rats with hereditary hepatitis: A model of Wilson’s disease. J Clin Invest 87:1858–1861.PubMedCrossRefGoogle Scholar
  24. 24.
    Pasquinelli C, Garreau F, Bougueleret L, Cariani E, Grzeschik KH, Thiers V, Croissant O, Hadchouel M, Tiollais P, Brechot C (1988) Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J Virol 62:629–632.PubMedGoogle Scholar
  25. 25.
    Buefow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S (1989) Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86:8852–8856.CrossRefGoogle Scholar
  26. 26.
    Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimure T, Miyamura T, Hirohashi S (1990) Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6791–6794.PubMedCrossRefGoogle Scholar
  27. 27.
    Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y (1991) Allelotype study of primary hepatocellular carcinoma. Cancer Res 51:89–93.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Minako Nagao
    • 1
  • Yoshinori Fujimoto
    • 1
  • Yukihito Ishizaka
    • 1
  • Katsuhiko Enomoto
    • 2
  • Hidetoshi Takahashi
    • 2
  • Michio Mori
    • 2
  • Takashi Sugimura
    • 1
  1. 1.Carcinogenesis DivisionNational Cancer Center Research InstituteTokyo, 104Japan
  2. 2.Department of PathologySapporo Medical CollegeSapporo, 060Japan

Personalised recommendations